文献速递糖尿病肥胖与代谢综合征

前肠排除增强Roux-en-Y胃旁路术后2型糖尿病患者的肠促胰岛素和胰岛素分泌

Foregut Exclusion Enhances Incretin and Insulin Secretion After Roux-en-Y Gastric Bypass in Adults With Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

本研究纳入15例接受Roux-en-Y胃旁路术(RYGB)的2型糖尿病患者,术中在胃残余放置胃造瘘管,随机交叉设计比较口服与胃造瘘管混合餐试验(术前及术后2周)。结果显示口服喂养显著增强胰岛素和肠促胰岛素分泌,而胃造瘘管喂养完全消除该效应;前肠排除可解释肠促胰岛素和胰岛素分泌增加,但可能不能完全解释术后早期糖代谢改善。

要点

  • RYGB术后2周口服喂养增强胰岛素和肠促胰岛素分泌,胃造瘘管喂养消除该效应
  • 前肠排除是肠促胰岛素和胰岛素分泌增加的主要机制
  • 前肠排除可能不能完全解释RYGB术后早期糖代谢改善

核心结论

  • 前肠排除可解释RYGB术后肠促胰岛素和胰岛素分泌的增加,但可能不能完全解释术后早期糖代谢的改善。

研究设计与样本

  • 研究为重复测量交叉设计,纳入15例接受RYGB的2型糖尿病患者,术中在胃残余放置胃造瘘管。
  • 患者随机接受口服或胃造瘘管混合餐耐受试验,分别在术前和术后2周进行。

主要发现

  • 术后2周体重、脂肪量、空腹血糖和胰岛素及循环血脂显著下降。
  • 口服喂养在RYGB术后显著增强胰岛素和肠促胰岛素分泌,而胃造瘘管喂养完全消除该效应。
  • 喂养的血糖反应以总曲线下面积计降低,但校正空腹血糖下降后差异不显著。

临床怎么用

  • 临床解读RYGB术后早期肠促胰岛素效应时需考虑前肠排除的作用,但糖代谢改善可能涉及其他机制。

局限性

  • 样本量较小(n=15),术后评估仅2周,机制解释需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients with type 2 diabetes experience resolution of hyperglycemia within days after Roux-en-Y gastric bypass (RYGB) surgery. This is attributed, in part, to enhanced secretion of hindgut factors following exclusion of the gastric remnant and proximal intestine during surgery. However, evidence of the mechanisms of remission remain limited due to the challenges of metabolic evaluation during the early postoperative period. The purpose of this investigation was to determine the role of foregut exclusion in the resolution of type 2 diabetes after RYGB. METHODS: Patients with type 2 diabetes (n = 15) undergoing RYGB had a gastrostomy tube (G-tube) placed in their gastric remnant at time of surgery. Patients were randomized to receive a mixed meal tolerance test via oral or G-tube feeding immediately prior to and 2 weeks after surgery in a repeated measures crossover design. Plasma glucose, insulin, C-peptide, incretin responses, and indices of meal-stimulated insulin secretion and sensitivity were determined. RESULTS: Body weight, fat mass, fasting glucose and insulin, and circulating lipids were significantly decreased 2 weeks after surgery. The glycemic response to feeding was reduced as a function of total area under the curve but not after adjustment for the reduction in fasting glucose. Oral feeding significantly enhanced insulin and incretin secretion after RYGB, which was entirely ablated by G-tube feeding. CONCLUSION: Foregut exclusion accounts for the rise in incretin and insulin secretion but may not fully explain the early improvements in glucose metabolism after RYGB surgery.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kirwan JP, Axelrod CL, Kullman EL, et al. Foregut Exclusion Enhances Incretin and Insulin Secretion After Roux-en-Y Gastric Bypass in Adults With Type 2 Diabetes. J Clin Endocrinol Metab. 2021. PMID: 33870426. doi:10.1210/clinem/dgab255

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。